Septerna, Inc

Tectonic Therapeutic

This biotechnology firm develops protein and antibody therapies targeting G-protein coupled receptors to treat patients with pulmonary hypertension and genetic bleeding disorders.

Sidera

This company develops small molecule medicines for patients with metabolic, inflammatory and kidney diseases using human genetic research findings.

Confo Therapeutics

Confo Therapeutics develops G-protein coupled receptor medicines for metabolic and endocrine diseases and provides drug discovery technology to global pharmaceutical companies.

Spruce Biosciences

This biopharmaceutical company develops enzyme replacement therapies and small molecules for patients with rare endocrine and neurological disorders.

Evommune

This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.

Eternygen

This biopharmaceutical company develops small molecule inhibitors targeting metabolic diseases, such as fatty liver and diabetes, for patients needing novel medical treatments.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Metsera

The company develops injectable and oral medicines for patients with obesity and metabolic diseases.